Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis

Oncotarget

Volumn 6, Issue 20, 2015, Pages 17911-17922

  Soutto, Mohammed ^a,b   Romero Gallo, Judith ^b   Krishna, Uma ^b   Blanca Piazuelo, M ^b   Kay Washington, M ^b   Belkhiri, Abbes ^b   Peek, Richard M ^b,c   El Rifai, Wael ^a,b,c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastric cancer; Helicobacter pylori; TFF1; catenin

Indexed keywords

BETA CATENIN; CYCLIN D1; MESSENGER RNA; PROTEIN KINASE B; CTNNB1 PROTEIN, HUMAN; CTNNB1 PROTEIN, MOUSE; PEPTIDE; TFF1 PROTEIN, HUMAN; TFF1 PROTEIN, MOUSE; TREFOIL FACTOR 1; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA CATENIN GENE; CANCER GROWTH; CCND1 GENE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GASTRIC CANCER CELL LINE; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE LOSS; GENE TARGETING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE C MYC; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; TFF1 GENE; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ACTIVE TRANSPORT; ADENOCARCINOMA; ANIMAL; CELL TRANSFORMATION; COMPLICATION; DEFICIENCY; DOWN REGULATION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; SIGNAL TRANSDUCTION; STOMACH MUCOSA; STOMACH TUMOR; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOCARCINOMA; ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE, KNOCKOUT; PEPTIDES; RNA, MESSENGER; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSFECTION; TREFOIL FACTOR-1; TUMOR SUPPRESSOR PROTEINS;

EID: 84938613538     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3772     Document Type: Article

References (51)

1. Tomasetto C, Masson R, Linares JL, Wendling C, Lefebvre O, Chenard MP, Rio MC. pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology. 2000; 118:70-80.
2. Tanaka T, Nakamura J, Kitajima Y, Kai K, Miyake S, Hiraki M, Ide T, Koga Y, Noshiro H. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer. Int J Oncol. 2013; 42:894-902.
3. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P, Rio MC. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science. 1996; 274:259-262.
4. Buache E, Etique N, Alpy F, Stoll I, Muckensturm M, Reina-San-Martin B, Chenard MP, Tomasetto C, Rio MC. Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice. Oncogene. 2011; 30:3261-3273.
5. Soutto M, Belkhiri A, Piazuelo MB, Schneider BG, Peng D, Jiang A, Washington MK, Kokoye Y, Crowe SE, Zaika A, Correa P, Peek RM Jr., El-Rifai W. Loss of TFF1 is associated with activation of NF-kappaB-mediated inflammation and gastric neoplasia in mice and humans. J Clin Invest. 2011; 121:1753-1767.
6. Katsha A, Soutto M, Sehdev V, Peng D, Washington MK, Piazuelo MB, Tantawy MN, Manning HC, Lu P, Shyr Y, Ecsedy J, Belkhiri A, El-Rifai W. Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia. Gastroenterology. 2013; 145:1312-1322. e1311-1318.
7. Soutto M, Peng D, Katsha A, Chen Z, Piazuelo MB, Washington MK, Belkhiri A, Correa P, El-Rifai W. Activation of beta-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis. Gut. 2014.
8. Park WS, Oh RR, Park JY, Lee JH, Shin MS, Kim HS, Lee HK, Kim YS, Kim SY, Lee SH, Yoo NJ, Lee JY. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology. 2000; 119:691-698.
9. Carvalho R, Kayademir T, Soares P, Canedo P, Sousa S, Oliveira C, Leistenschneider P, Seruca R, Gott P, Blin N, Carneiro F, Machado JC. Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma. Lab Invest. 2002; 82:1319-1326.
10. Tomita H, Takaishi S, Menheniott TR, Yang X, Shibata W, Jin G, Betz KS, Kawakami K, Minamoto T, Tomasetto C, Rio MC, Lerkowit N, Varro A, Giraud AS, Wang TC. Inhibition of gastric carcinogenesis by the hormone, gastrin, is mediated by suppression of TFF1 epigenetic silencing. Gastroenterology. 2010.
11. McChesney PA, Aiyar SE, Lee OJ, Zaika A, Moskaluk C, Li R, El-Rifai W. Cofactor of BRCA1: a novel transcription factor regulator in upper gastrointestinal adenocarcinomas. Cancer Res. 2006; 66:1346-1353.
12. Im S, Yoo C, Jung JH, Choi HJ, Yoo J, Kang CS. Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis. Int J Med Sci. 2013; 10:133-140.
13. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012; 149:1192-1205.
14. Zhang HF, Xue YW. Wnt pathway is involved in advanced gastric carcinoma. Hepato-Gastroenterol. 2008; 55:1126-1130.
15. Polakis P. Wnt signaling and cancer. Genes & development. 2000; 14:1837-1851.
16. Li L, Ji SY, Yang JL, Li XX, Zhang J, Zhang Y, Hu ZY, Liu YX. Wnt/beta-catenin signaling regulates follicular development by modulating the expression of Foxo3a signaling components. Mol Cell Endocrinol. 2014; 382:915-925.
17. Yang Y, Yang JJ, Tao H, Jin WS. New perspectives on beta-catenin control of cell fate and proliferation in colon cancer. Food Chem Toxicol. 2014; 74:14-19.
18. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984; 1:1311-1315.
19. Nomura A, Stemmermann G, Chyou P, Kato I, Perez-Perez G, Blaser M. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991; 325:1132-1136.
20. Parsonnet J, Friedman G, Vandersteen D. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991; 325:1127-1131.
21. Matysiak-Budnik T, Laszewicz W, Lamarque D, Chaussade S. Helicobacter pylori and non-malignant diseases. Helicobacter. 2006; 11:27-31. Suppl 1.
22. Oliveira MJ, Costa AM, Costa AC, Ferreira RM, Sampaio P, Machado JC, Seruca R, Mareel M, Figueiredo C. CagA associates with c-Met, E-cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype. The Journal of infectious diseases. 2009; 200:745-755.
23. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nature reviews Cancer. 2004; 4:688-694.
24. Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Perez-Perez GI, Hatakeyama M, Whitehead R, Gaus K, O'Brie DP, Romero-Gallo J, Peek RM Jr. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A. 2005; 102:10646-10651.
25. Bebb JR, Leach L, Zaitoun A, Hand N, Letley DP, Thomas R, Atherton JC. Effects of Helicobacter pylori on the cadherin-catenin complex. Journal of clinical pathology. 2006; 59:1261-1266.
26. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM Jr., Azuma T, Hatakeyama M. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007; 26:4617-4626.
27. Guang W, Czinn SJ, Blanchard TG, Kim KC, Lillehoj EP. Genetic regulation of MUC1 expression by Helicobacter pylori in gastric cancer cells. Biochemical and biophysical research communications. 2014; 445:145-150.
28. Boltin D, Niv Y. Mucins in Gastric Cancer-An Update. Journal of gastrointestinal & digestive system. 2013; 3:15519.
29. Micu G, Staniceanu F, Zurac S, Bastian A, Gramada E, Popp C, Andrei R, Tudorica L, Slavnea A, Olariu M, Tebeica T, Ene A, Mateescu R, Rimbas M, Voiosu R. E-cadherin and beta-catenin expression in gastric neoplastic and non-neoplastic lesions-correlations with H. pylori infection. Rom J Intern Med. 2010; 48:271-280.
30. Gnad T, Feoktistova M, Leverkus M, Lendeckel U, Naumann M. Helicobacter pylori-induced activation of beta-catenin involves low density lipoprotein receptor-related protein 6 and Dishevelled. Mol Cancer. 2010; 9:31.
31. Hatakeyama M. Helicobacter pylori and gastric carcinogenesis. J Gastroenterol. 2009; 44:239-248.
32. Kim IJ, Park JH, Kang HC, Shin Y, Lim SB, Ku JL, Yang HK, Lee KU, Park JG. A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancer. J Med Genet. 2003; 40:e97.
33. Soutto M, Chen Z, Saleh MA, Katsha A, Zhu S, Zaika A, Belkhiri A, El-Rifai W. TFF1 activates p53 through down-regulation of miR-04 in gastric cancer. Oncotarget. 2014; 5:5663-5673.
34. Wroblewski LE, Piazuelo MB, Chaturvedi R, Schumacher M, Aihara E, Feng R, Noto JM, Delgado A, Israel DA, Zavros Y, Montrose MH, Shroyer N, Correa P, Wilson KT, Peek RM Jr. Helicobacter pylori targets cancer-associated apical-junctional constituents in gastroids and gastric epithelial cells. Gut. 2014.
35. Lee DG, Kim HS, Lee YS, Kim S, Cha SY, Ota I, Kim NH, Cha YH, Yang DH, Lee Y, Park GJ, Yook JI, Lee YC. Helicobacter pylori CagA promotes Snail-mediated epithelial-mesenchymal transition by reducing GSK-3 activity. Nat Commun. 2014; 5:4423.
36. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science. 2003; 300:1430-1434.
37. Ebert MP, Fei G, Kahmann S, Muller O, Yu J, Sung JJ, Malfertheiner P. Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis. 2002; 23:87-91.
38. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, Groden J, Lowy AM. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 2002; 62:3503-3506.
39. Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, Peek RM Jr. Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology. 2003; 125:1125-1136.
40. Romano M, Ricci V, Di Popolo A, Sommi P, Del Vecchio Blanco C, Bruni CB, Ventura U, Cover TL, Blaser MJ, Coffey RJ, Zarrilli R. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. J Clin Invest. 1998; 101:1604-1613.
41. Nagy TA, Wroblewski LE, Wang D, Piazuelo MB, Delgado A, Romero-Gallo J, Noto J, Israel DA, Ogden SR, Correa P, Cover TL, Peek RM Jr. beta-Catenin and p120 mediate PPARdelta-dependent proliferation induced by Helicobacter pylori in human and rodent epithelia. Gastroenterology. 2011; 141:553-564.
42. Peek RM Jr., Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature reviews Cancer. 2002; 2:28-37.
43. Imrie C, Rowland M, Bourke B, Drumm B. Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics. 2001; 107:373-380.
44. Styer CM, Hansen LM, Cooke CL, Gundersen AM, Choi SS, Berg DE, Benghezal M, Marshall BJ, Peek RM Jr., Boren T, Solnick JV. Expression of the BabA adhesin during experimental infection with Helicobacter pylori. Infect Immun. 2010; 78:1593-1600.
45. Solnick JV, Hansen LM, Salama NR, Boonjakuakul JK, Syvanen M. Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proc Natl Acad Sci U S A. 2004; 101:2106-2111.
46. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, Smith DR, Noonan B, Guild BC, deJonge BL, Carmel G, Tummino PJ, Caruso A, Uria-Nickelsen M, Mills DM, IvesC, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 1999; 397:176-180.
47. Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA, Wroblewski LE, Piazuelo MB, Correa P, Peek RM Jr. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res. 2008; 68:379-387.
48. Arnold IC, Lee JY, Amieva MR, Roers A, Flavell RA, Sparwasser T, Muller A. Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology. 2011; 140:199-209.
49. Smale ST. Beta-galactosidase assay. Cold Spring Harbor protocols. 2010; 2010. pdbprot5423.
50. El-Rifai W, Powell S. Molecular and biologic basis of upper gastrointestinal malignancy gastric carcinoma. Surgical Oncology Clinics of North America. 2002; 11:273-291.
51. Fox JG, Wang TC, Rogers AB, Poutahidis T, Ge Z, Taylor N, Dangler CA, Israel DA, Krishna U, Gaus K, Peek RM Jr. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology. 2003; 124:1879-1890.